[HTML][HTML] Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an …

…, R Perez-Alamino, JA Maldonado-Cocco… - Medicine, 2016 - journals.lww.com
… h Hospital Universitario “José Eleuterio González,” Monterrey … Maldonado-Cocco,
Section of Rheumatology—Instituto de Rehabilitación Psicofísica, Echeverria, Buenos Aires …

Validation and crosscultural adaptation of an Argentine Spanish version of the Health Assessment Questionnaire disability index

…, MS Arriola, JA Maldonado-Cocco… - JCR: Journal of …, 2004 - journals.lww.com
Background: The Health Assessment Questionnaire (HAQ) is one of the most frequently
used instruments to assess functional capacity in activities of daily living. Objective: The …

Adherence to treatment in patients with ankylosing spondylitis

…, E Buschiazzo, C Ledesma, JA Maldonado Cocco… - Clinical …, 2013 - Springer
This study aims to determine the level of adherence to treatment in ankylosing spondylitis (AS)
patients and to identify possible factors associated to lack of adherence. We included …

Polyarteritis nodosa revisited

I Colmegna, JA Maldonado-Cocco - Current rheumatology reports, 2005 - Springer
… Nodosa Revisited • Colmegna and Maldonado-Cocco … Nodosa Revisited • Colmegna
and Maldonado-Cocco … Polyarteritis Nodosa Revisited • Colmegna and Maldonado-Cocco

Prospective study of the early course of rheumatoid arthritis in young adults: comparison of patients with and without rheumatoid factor positivity at entry and …

AT Masi, JA Maldonado-Cocco, SB Kaplan… - Seminars in arthritis and …, 1976 - Elsevier
MATERIALS AND METHODS All available young adult (16-44 yr) arthritis patients entered
into the Memphis and Shelby County Arthritis Research Program (ARP) with an initial study …

Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up

…, JJ Gomez-Reino, JA Maldonado-Cocco… - …, 2020 - academic.oup.com
Objective Sarilumab is a human monoclonal antibody that blocks IL-6 from binding to
membrane-bound and soluble IL-6 receptor-α. We assessed the long-term safety of sarilumab in …

Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus …

…, JJ Gómez-Reino, A Kivitz, JA Maldonado-Cocco… - RMD open, 2019 - rmdopen.bmj.com
Objective In MOBILITY ( NCT01061736 ), sarilumab significantly reduced disease activity,
improved physical function and inhibited radiographic progression at week 52 versus placebo …

Fatigue assessment and its impact in the quality of life of patients with ankylosing spondylitis

…, MF Marengo, F Dal Pra, JA Maldonado Cocco… - Clinical …, 2015 - Springer
The most frequently reported symptoms by patients with ankylosing spondylitis (AS) are pain,
stiffness, and fatigue. Previous studies have estimated a 63 % prevalence of fatigue in AS, …

Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease

RP Alamino, JAM Cocco, G Citera, P Arturi… - The Journal of …, 2011 - jrheum.org
Objective. To describe differential characteristics of axial involvement in ankylosing
spondylitis (AS) as compared with that seen in psoriatic arthritis (PsA) and inflammatory bowel …

Clinical and serologic characterization of an Argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein

G Espada, JAM Cocco, N Fertig, CV Oddis - The Journal of …, 2009 - jrheum.org
Objective. Autoantibodies are frequently found in adult patients with polymyositis (PM),
dermato-myositis (DM), and overlap myositis disorders. They are less common in pediatric …